Cargando…
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
Vaccines are the most effective means to prevent the potentially deadly effects of SARS-CoV-2 infection, but not all vaccinated individuals gain the same degree of protection. Patients undergoing chronic immunosuppressive therapy due to autoimmune diseases or liver transplants, for example, may show...
Autores principales: | Zecca, Erika, Rizzi, Manuela, Tonello, Stelvio, Matino, Erica, Costanzo, Martina, Rizzi, Eleonora, Casciaro, Giuseppe Francesco, Manfredi, Giulia Francesca, Acquaviva, Antonio, Gagliardi, Ileana, Calzaducca, Elisa, Mallela, Venkata Ramana, D’Onghia, Davide, Minisini, Rosalba, Bellan, Mattia, Castello, Luigi Mario, Gavelli, Francesco, Avanzi, Gian Carlo, Patrucco, Filippo, Chiocchetti, Annalisa, Pirisi, Mario, Rigamonti, Cristina, Lilleri, Daniele, Sola, Daniele, Sainaghi, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413351/ https://www.ncbi.nlm.nih.gov/pubmed/36016388 http://dx.doi.org/10.3390/v14081766 |
Ejemplares similares
-
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
por: Rizzi, Manuela, et al.
Publicado: (2023) -
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022) -
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
por: Rizzi, Manuela, et al.
Publicado: (2022) -
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
por: Rizzi, Manuela, et al.
Publicado: (2023) -
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022)